학술논문
Predictive Biomarkers of Response to the Polo-like Kinase 1 (PLK1) Inhibitor, Onvansertib, in Combination with Decitabine in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
Document Type
Abstract
Author
Source
In Blood 23 November 2021 138 Supplement 1:3431-3431
Subject
Language
ISSN
0006-4971